Publication Name	World Journal of Stem Cells
Manuscript ID	98522
Country	Taiwan

Received	2024-06-28 03:08
Peer-Review Started	2024-06-28 03:08
To Make the First Decision
Return for Revision	2024-07-11 04:47
Revised	2024-07-24 12:44
Second Decision	2024-08-09 02:43
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-08-09 05:54
Articles in Press	2024-08-09 05:54
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-08-22 04:38
Publish the Manuscript Online	2024-08-26 05:32

ISSN	1948-0210 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Medicine, Research & Experimental
Manuscript Type	Editorial
Article Title	Mesenchymal stem cells: A promising therapeutic avenue for non-alcoholic fatty liver disease
Manuscript Source	Invited Manuscript
All Author List	Chun-Han Cheng, Wen-Rui Hao and Tzu-Hurng Cheng
ORCID	Author(s) ORCID Number Tzu-Hurng Cheng http://orcid.org/0000-0002-9155-4169
Funding Agency and Grant Number
Corresponding Author	Tzu-Hurng Cheng, PhD, Professor, Department of Biochemistry, School of Medicine, College of Medicine, China Medical University, No. 91 Xueshi Road, North District, Taichung 404328, Taiwan. thcheng@mail.cmu.edu.tw
Key Words	Mesenchymal stem cells; Non-alcoholic fatty liver disease; Therapeutic potential; Liver fibrosis; Regenerative medicine; Stem cell therapy; Inflammation; Clinical trials
Core Tip	Mesenchymal stem cells (MSCs) constitute a promising therapy for non-alcoholic fatty liver disease. Expanding upon insights from the forthcoming study by Jiang et al. MSCs demonstrate potent immunomodulatory and anti-inflammatory effects and can promote liver tissue regeneration. Addressing challenges such as MSC heterogeneity and ensuring long-term safety through standardized protocols are crucial to harnessing the full therapeutic potential of MSCs in clinical settings.
Publish Date	2024-08-26 05:32
Citation	<p>Cheng CH, Hao WR, Cheng TH. Mesenchymal stem cells: A promising therapeutic avenue for non-alcoholic fatty liver disease. <i>World J Stem Cells</i> 2024; 16(8): 780-783</p>
URL	https://www.wjgnet.com/1948-0210/full/v16/i8/780.htm
DOI	https://dx.doi.org/10.4252/wjsc.v16.i8.780

Full Article (PDF)	WJSC-16-780-with-cover.pdf
Manuscript File	98522_Auto_Edited_065426.docx
Answering Reviewers	98522-answering-reviewers.pdf
Audio Core Tip	98522-audio.mp3
Conflict-of-Interest Disclosure Form	98522-conflict-of-interest-statement.pdf
Copyright License Agreement	98522-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate	98522-non-native-speakers.pdf
Peer-review Report	98522-peer-reviews.pdf
Scientific Misconduct Check	98522-scientific-misconduct-check.png
Scientific Editor Work List	98522-scientific-editor-work-list.pdf
CrossCheck Report	98522-crosscheck-report.pdf